Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(10):2249-2257.
doi: 10.1080/21645515.2019.1633875. Epub 2019 Jul 16.

Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease

Joel N Maslow  1   2 , Jackie J Kwon  1 , Susan K Mikota  1 , Susan Spruill  1 , Youngran Cho  1 , Moonsup Jeong  1
Affiliations
Review

Severe fever and thrombocytopenia syndrome virus infection: Considerations for vaccine evaluation of a rare disease

Joel N Maslow et al. Hum Vaccin Immunother. 2019.

Abstract

Infection caused by the severe fever and thrombocytopenia syndrome virus (SFTSV) causes a hemorrhagic illness with a mortality between 20% and 40%. Initially recognized in 2009 in China, cases have additionally been documented in Japan and Korea although retrospective studies have documented seroprevalence since 1996. Although case rates have increased due to increased awareness and more widely available diagnostics, SFTSV infection remains rare with the highest rates documented in Korea for Jeju Province (3.5 cases per 100,000 population) and the Inje-gun region (66.2 cases per 100,000). Because of the very low incidence of infection, a placebo-controlled study with 1:1 randomization to evaluate an SFTSV vaccine would require a sample size that is 25% greater than the region of study. We discuss alternatives to licensure. Vaccine effectiveness may be assessed through a registry, comparing rates of infection over time between vaccine recipients versus regional populations. Modeled data can be updated based on actual case rates and population changes over the years of follow-up. Using one model, statistically significant differences are seen after 10 years in Inje-gun and 15 years of follow-up in Jeju. This approach may be applicable to other uncommon infectious diseases for which a standard study design is difficult.

Keywords: SFTS virus; clinical trial design; emerging infectious disease; rare disease; sample size estimate; seroprevalence; severe fever and thrombocytopenia virus.

PubMed Disclaimer

References

    1. Yu XJ, Liang MF, Zhang SY, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364:1523–32. - PMC - PubMed
    1. Kim KH, Lee MJ, Ko MK, Lee EY, Yi J.. Severe fever with thrombocytopenia syndrome patients with hemophagocytic lymphohistiocytosis retrospectively identified in Korea, 2008-2013. J Korean Med Sci. 2018;33(50):e319. doi: 10.3346/jkms.2018.33.e319. - DOI - PMC - PubMed
    1. Kitao A, Ieki R, Takatsu H, Tachibana Y, Nagae M, Hino T, Nakaji H, Shimojima M, Saijo M, Okayama M, et al. Severe fever with thrombocytopenia syndrome presenting as hemophagocytic syndrome: two case reports. Springerplus. 2016;5:361. doi: 10.1186/s40064-016-2010-2. - DOI - PMC - PubMed
    1. Nakano A, Ogawa H, Nakanishi Y, Okada H. Hemophagocytic lymphohistiocytosis in a fatal case of severe fever with thrombocytopenia syndrome. Intern Med. 2017;56:1597–602. - PMC - PubMed
    1. Hiraki T, Yoshimitsu M, Suzuki T, Goto Y, Higashi M, Yokoyama S, Tabuchi T, Futatsuki T, Nakamura K, Hasegawa H, et al. Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS. Pathol Int. 2014;64:569–75. - PMC - PubMed

MeSH terms